Cytokinetics ticker
WebCytokinetics is a biopharmaceutical company with a focus on the discovery, development, and commercialization of muscle activators and muscle inhibitors as potential treatments … WebFeb 17, 2024 · It is currently -18.08% from its 52-week high and 51.01% from its 52-week low. How much is Cytokinetics stock worth today? ( NASDAQ: CYTK) Cytokinetics currently has 94,631,001 outstanding shares. With Cytokinetics stock trading at $45.71 per share, the total value of Cytokinetics stock (market capitalization) is $4.33B.
Cytokinetics ticker
Did you know?
WebDec 30, 2024 · Cytokinetics, Incorporated is a late-stage biopharmaceutical company. It is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases. It is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. WebCytokinetics (CYTK) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. ... Stock Ticker Symbol Market Type; Cytokinetics Inc: CYTK: NASDAQ: Common Stock Price Change Change Percent Stock Price Last Traded -1.73-4.67%: 35.33: 20:00:00: Open Price Low Price High Price
Web2 days ago · Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as … WebDec 13, 2024 · PDUFA Target Action Date is February 28, 2024 Cytokinetics to Host Conference Call and Webcast on December 14, 2024 at 8:30 am Eastern Time SOUTH SAN FRANCISCO, Calif., Dec. 13, 2024 (GLOBE ...
WebCytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential …
WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 …
WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating … iron wrought ottoman coffee tableWebCytokinetics Inc. Annual stock financials by MarketWatch. View the latest CYTK financial statements, income statements and financial ratios. iron wrought gateWebJul 19, 2024 · The data suggest that Cytokinetics (ticker: CYTK) drug could become a potent rival to a similar investigational drug that Bristol Myers Squibb (BMY) acquired last … iron x handrails for stepsWebCytokinetics Stock Price Today NASDAQ CYTK Live Ticker - Investing.com Stock Screener United States Pre-Market World ADRs Stock Brokers Fed Rate Monitor Tool Cytokinetics Inc (CYTK)... iron x cleanerWebTicker CYTK. Exchange NASDAQ More. ... Cytokinetics is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. Visit website. Social Media Links. Cytokinetics. Most Recent … iron x fallout removerWebApr 6, 2024 · Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as … iron wrought railingWebMar 16, 2024 · Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle … port throttled brocade